149 related articles for article (PubMed ID: 38204237)
1. MiR-29b Alleviates High Glucose-induced Inflammation and Apoptosis in Podocytes by Down-regulating PRKAB2.
Du H; Wang Y; Zhu Y; Li X; Zhu T; Wu Q; Zha F
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):981-990. PubMed ID: 38204237
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Linc 4930556M19Rik Suppresses High Glucose-Triggered Podocyte Apoptosis, Fibrosis and Inflammation via the miR-27a-3p/Metalloproteinase 3 (TIMP3) Axis in Diabetic Nephropathy.
Fan H; Zhang W
Med Sci Monit; 2020 Sep; 26():e925361. PubMed ID: 32896839
[TBL] [Abstract][Full Text] [Related]
3. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
Wang L; Li H
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
5. KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A.
Fei B; Zhou H; He Z; Wang S
Clin Exp Nephrol; 2022 May; 26(5):385-397. PubMed ID: 34997887
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
[TBL] [Abstract][Full Text] [Related]
7. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A.
Fu Y; Wang C; Zhang D; Chu X; Zhang Y; Li J
J Cell Physiol; 2019 Nov; 234(11):20869-20878. PubMed ID: 31025335
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9.
Fang R; Cao X; Zhu Y; Chen Q
Autoimmunity; 2022 Jun; 55(4):254-263. PubMed ID: 35285770
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1.
Yang H; Wang Q; Li S
Biochem Biophys Res Commun; 2016 Mar; 471(4):582-8. PubMed ID: 26876575
[TBL] [Abstract][Full Text] [Related]
10. Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis.
Zhang M; Zhao S; Xu C; Shen Y; Huang J; Shen S; Li Y; Chen X
Biochem Biophys Res Commun; 2020 Dec; 533(3):429-436. PubMed ID: 32972755
[TBL] [Abstract][Full Text] [Related]
11. LncRNA 1500026H17Rik knockdown ameliorates high glucose-induced mouse podocyte injuries through the miR-205-5p/EGR1 pathway.
Xia J; Sun W; Dun J
Int Urol Nephrol; 2023 Apr; 55(4):1045-1057. PubMed ID: 36306049
[TBL] [Abstract][Full Text] [Related]
12. CircGAB1 Facilitates Podocyte Injury Through Sponging miR-346 and Activating MAPK6 in Diabetic Nephropathy.
Ma P; He Y; Wang B; Qiu D; Xu Q
Appl Biochem Biotechnol; 2024 Apr; 196(4):1863-1875. PubMed ID: 37440116
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of mm9_circ_013935 alleviates renal inflammation and fibrosis in diabetic nephropathy via the miR-153-3p/NFIC axis.
Zhang L; Zhang L; Li S; Zhang Q; Luo Y; Zhang C; Huan Q; Zhang C
Can J Physiol Pharmacol; 2021 Nov; 99(11):1199-1206. PubMed ID: 34197715
[TBL] [Abstract][Full Text] [Related]
14. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
15. [MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway].
Wang H; Liu H; Zhang Y; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1839-1845. PubMed ID: 36651252
[TBL] [Abstract][Full Text] [Related]
16. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
Wang J; Shen L; Hong H; Li J; Wang H; Li X
Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
[TBL] [Abstract][Full Text] [Related]
17. microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF/PDK4 axis.
Zhao T; Jin Q; Kong L; Zhang D; Teng Y; Lin L; Yao X; Jin Y; Li M
J Bioenerg Biomembr; 2022 Feb; 54(1):17-30. PubMed ID: 34806156
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice.
Wang X; Gao Y; Yi W; Qiao Y; Hu H; Wang Y; Hu Y; Wu S; Sun H; Zhang T
J Diabetes Res; 2021; 2021():5597394. PubMed ID: 33748285
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
Lei X; Zhang BD; Ren JG; Luo FL
Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
